10-Q · May 8, 2026
AirSculpt Technologies reported essentially flat revenue of $39.4 million for the three months ended March 31, 2026, compared to the same period in 2025. The company achieved a net loss of $2.4 million, an improvement…
Earnings analysis · 10-Q
Filed August 10, 2026 · Our reading of the company's report
The latest report
AirSculpt reported Q2 revenue of $42.9 million and diluted EPS of negative $0.02, below consensus revenue of $44.1 million and EPS of $0.02; same-center case volume nevertheless grew 1.0%. Liquidity timing improved…
AirSculpt reported Q2 revenue of $42.9 million and diluted EPS of negative $0.02, below consensus revenue of $44.1 million and EPS of $0.02; same-center case volume nevertheless grew 1.0%. Liquidity timing improved through the November 15, 2027 debt maturity extension, but the company must make two $2.5 million payments and faces a refinancing or discharge deadline of October 31, 2026. Persistent material weaknesses as of June 30, 2026 and lower adjusted EBITDA guidance of $12 million to $14 million outweigh the modest volume growth.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Q2 revenue was $42.9 million and same-center case volume increased 1.0%, indicating modest underlying demand growth despite the revenue shortfall versus the $44.1 million consensus estimate.
The Fourth Amendment extends the term loan and revolving facility maturity to November 15, 2027, approximately six months beyond the prior May 11, 2027 maturity date.
Management engaged external accounting advisors and is enhancing lease-accounting and financial-close controls during 2026 to address identified reporting deficiencies.
The company reaffirmed 2026 revenue guidance of $151 million to $157 million, although management expects performance at the lower end of that range.
Management concluded disclosure controls were not effective as of June 30, 2026. Material weaknesses in general accounting and financial reporting and lease accounting under ASC 842 continued to exist and had not been fully remediated.
The credit amendment requires a $2.5 million payment upon signing and an additional $2.5 million payment by September 30, 2026. It also requires 50% of future non-plan equity proceeds to prepay term loans.
If the discharge of obligations has not occurred by October 31, 2026, the company must retain investment banks to pursue replacement debt refinancing or another transaction, increasing refinancing and liquidity risk.
Q2 diluted EPS was a loss of $0.02 versus the $0.02 consensus estimate, while revenue of $42.9 million was below the $44.1 million estimate. Adjusted EBITDA declined to $4.9 million from $5.8 million, and 2026 adjusted EBITDA guidance was reduced to $12 million to $14 million.
The supplied 10-Q does not provide numeric EPS or revenue guidance. The contemporaneous outlook cited in the earnings materials reaffirmed 2026 revenue guidance of $151 million to $157 million, with results expected at the lower end of the range, and reduced adjusted EBITDA guidance to $12 million to $14 million.
AirSculpt Technologies reported essentially flat revenue of $39.4 million for the three months ended March 31, 2026, compared to the same period in 2025. The company achieved a net loss of $2.4 million, an improvement…
AirSculpt’s 2025 10-K emphasizes its differentiated AirSculpt® method, a 31-center footprint (U.S. & Canada) and attractive unit economics (2025 revenue per case $12,809; 11,852 procedures in 2025), but reports material…
AirSculpt reported third-quarter revenue of $34,993,000 and a GAAP net loss of $9,512,000 (loss per share $0.15), with operating loss widening to $9,750,000. The quarter included $7,137,000 of impairment charges…
AirSculpt reported Q2 revenue of $44,012 (in $000s) and a quarter with operating income of $786 (in $000s), a meaningful operational improvement versus the prior-year operating loss. Revenue declined versus Q2 2024, but…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.